In consultation: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Consultation end date

Consultation end date

Type 1 selected

Type

Guidance programme

Showing 1 to 15 of 15

TitleConsultationTypeConsultation end date
Apadamtase alfa for treating congenital thrombotic thrombocytopenic purpura caused by ADAMTS-13 deficiency [ID6192]Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Baxdrostat for treating uncontrolled or resistant hypertension [ID6623]Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Cemiplimab for adjuvant treatment of high-risk cutaneous squamous cell carcinoma after surgery and radiotherapy [ID6659]Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Decitabine–cedazuridine with venetoclax for treating acute myeloid leukaemia when intensive induction chemotherapy is unsuitable [ID6601]Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Ectopic pregnancy and miscarriage: diagnosis and initial management (update)Draft guidance consultationNICE guideline
Enfortumab vedotin with pembrolizumab for neoadjuvant and adjuvant treatment of muscle-invasive bladder cancer [ID6607]Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Guidance on the use of electroconvulsive therapyReview proposal consultationTechnology appraisal guidance
Inhaled treprostinil for treating pulmonary hypertension with interstitial lung disease [ID6459]Draft guidanceTechnology appraisal guidance
MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremorDraft scope consultationInterventional procedures guidance
Osteoporosis: risk assessment, treatment, and fragility fracture prevention (update)Draft guidance consultationNICE guideline
Pembrolizumab with chemoradiation for untreated high-risk locally advanced cervical cancer [ID6138]Draft guidanceTechnology appraisal guidance
Percutaneous insertion of a cerebral protection device during TAVI for preventing strokeDraft scope consultationInterventional procedures guidance
Pimicotinib for treating tenosynovial giant cell tumours when systemic treatment is needed [ID6647]Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Pirtobrutinib for untreated chronic lymphocytic leukaemia or small lymphocytic lymphoma [ID6397]Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Serplulimab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer [ID6346]Draft guidanceTechnology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All